| 生物活性 | Pectolinarigenin is an orally active dual COX-2/5-LOX inhibitor with anti-inflammatory, antioxidant, antitumor, and neuroprotective activities; it exerts neuroprotective and anti-inflammatory effects on astrocyte inflammation through the NFκB and MAPK pathways, inhibits LPS-induced phosphorylation of ERK1/2, NFκB, and p38MAPK, directly inhibits the enzymatic activity or binding of COX-2, 5-LOX, and HIF-1α, and reduces XIAP levels; it also modifies Keap1 to promote nuclear accumulation of Nrf2, induces ARE-mediated antioxidant enzyme expression, and possesses direct free radical scavenging capacity; furthermore, it reduces the release of NO, pro-inflammatory mediators, and leukotrienes while increasing IL-10 levels, induces G2/M phase cell cycle arrest, apoptosis, and autophagy through the PI3K/AKT/mTOR signaling pathway, reduces renal crystal deposition, inhibits melanin synthesis, suppresses inflammation and alleviates allergy in mouse inflammation models, and alleviates renal injury, inflammation, and oxidative stress in mice by inhibiting HIF-1α activity; therefore, it can be used for research on neurodegenerative diseases, inflammatory/allergic diseases, calcium oxalate nephrocalcinosis, gastric cancer, melanoderma, post-inflammatory conditions, and chloasma. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| IC50 & Target |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 体外研究 (In Vitro) |
Pectolinarigenin (5-160 μM; 24 h) 在 160 μM 浓度下会降低 J774A.1 小鼠巨噬细胞存活率,可抑制 LPS (MS-X54539) 诱导的 J774A.1 小鼠巨噬细胞中 NO 的释放。 Cell Viability Assay
Immunofluorescence
Western Blot Analysis
Western Blot Analysis
Cell Viability Assay
Cell Cycle Analysis
Apoptosis Analysis
Cell Autophagy Assay
Western Blot Analysis
Real Time qPCR
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 体内研究 (In Vivo) |
Pectolinarigenin (4-100 mg/kg; p.o.; single dose) 以 100 mg/kg 经口给药时,可对 Arachidonic acid (MS-A69140) 诱导的小鼠耳水肿产生抑制作用。
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 性状 | 固体 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 颜色 | Light yellow to yellow |
| 分子量 | 314.29 |
| 分子式 | C17H14O6 |
| CAS No. | 520-12-7 |
| 别名 | 柳穿鱼黄素 |
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 0.96 mg/mL (3.05 mM), Solution. 10% DMSO+90% Saline: 2.50 mg/mL (7.95 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 储存方式 | 4°C, protect from light *In solvent: -80°C, 6 months; -20°C, 1 month (protect from light) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 运输条件 | Room temperature in continental US; may vary elsewhere. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
溶液配制表
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
DMSO 中的溶解度 : 33.33 mg/mL (106.05 mM; 超声助溶; 吸湿的 DMSO 对产品的溶解度有显著影响,请使用新开封的 DMSO)
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。
该溶液配制表仅适用于固体产品。对于液体产品,请根据标明的浓度或密度计算稀释方案。
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:
比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。